We are pleased to announce that you can apply for the LIVE Master intake 2025-2027  (M1+M2, 2-year Program) or 2025-2026 (M2-only, 1-year Program) as follow:Application period #2 (open): From February 25 to May

We are pleased to publish theINTERVIEW SCHEDULEto apply for the Erasmus Mundus Joint Master "Leading International Vaccinology Education - LIVE" Master class 2025-2026/27 for the Period #1 (Nov 2024 to Jan 2025): for candidates

The United States is a fascinating country to explore. In my first few days, I have immersed myself in its rich history and culture by visiting the Smithsonian museums in Washington, D.C.. I also

Festive season...As the festive season envelops us in its spirit of warmth and joy, we pause to share a heartfelt holiday message from the LIVE team to YOU. This year, we are also

2024 LIVE_Innov Grant Agreement SignatureWe are delighted to announce that the LIVE Consortium has signed a third Grant Agreement with the EACEA awarding the quality label "Erasmus Mundus Joint Master - EMJM" to

Feedback from the XVIII Congress of the Catalan Society of ImmunologyOur Belkaid prom of the MASTER LIVE had the opportunity to participate in the CSI congress held on November 21-22, 2024 in Barcelona.

On November 12th, 2024, the Belkaid class had the opportunity to visit the Barcelona Supercomputing Center (BSC) and learn more about the applications of supercomputers in fields such as computer sciences, life sciences

Announcing the LIVE 2024 Promotion Name: A Tribute to Professor Yasmine BelkaidAs we embark on our transformative two-year journey in the Leading International Vaccinology Education for Innovation (LIVE_Innov) program, we, the students of

Highlighting the Achievements of the Karikó Cohort (2022-2024) in the LIVE ProgramJune 17-19, 2024, the La Doua campus of Université Lyon 1 in France hosted a remarkable event celebrating the Katalin Karikó cohort of

At the global HQ office for Moderna in Cambridge, MA, USA My experience as a LIVE master intern at Moderna in Cambridge MA (USA)Working as a pharmacist within Uganda’s National Drug Authority (NDA) sparked